Membranoproliferative Glomerulonephritis
Nephrology
Prevalence
30.0 / 100K
2 drugs in development·1 company·4 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| ach-4471 | ACHILLION PHARMACEUTICALS INC (ACHN) |
Preclinical(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Membranoproliferative Glomerulonephritis?
BioSniper tracks 2 drugs in development for Membranoproliferative Glomerulonephritis across 1 company.
How many clinical trials target Membranoproliferative Glomerulonephritis?
There are 4 clinical trials targeting Membranoproliferative Glomerulonephritis tracked by BioSniper.
What is the prevalence of Membranoproliferative Glomerulonephritis?
The estimated prevalence of Membranoproliferative Glomerulonephritis is approximately 30.0 per 100,000 population.
Deep-dive into Membranoproliferative Glomerulonephritis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis